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Abstract 
Background: Oxidative stress (OxS) is a disturbance associated with the pathogenesis of diabetes/pre-
diabetes, obesity, cancer, ageing, inflammation, apoptosis, neurodegenerative disorders and 
cardiovascular diseases. Metabolic syndrome (MetS), also called insulin-resistance syndrome, is a 
complex of disorders, each of which contributes to cardiovascular risk, associated with imbalance 
between production and inactivation of reactive oxygen species. In the last years the potential role of 
OxS in MetS is rapidly evolving. 
Methods: The present study was designed to investigate the effect of Piracetam, Resveratrol and 
propylene glycol extract of Royal jelly on behavioral functions and OxS markers in serum of fructose-
drinking rats. 
Results: MetS induced by 60% fructose solution in rats leads to impairment of cognitive functions, based 
on the development of OxS. Royal jelly extract and Resveratrol show pronounced antiamnesic activity in 
rats with MetS. All studied drugs inhibit reactions of free radical oxidation in varying degree. 
Conclusions: This study indicates an important role of OxS in the development of cognitive disorders 
that appear in consequence of MetS. In experimental model of MetS the largest antiamnesic and 
antiradical efficacy was observed for propylene glycol extract of Royal jelly. 
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Introduction 
Metabolic syndrome (MetS) has become a leading global health problem owing to its 
association with a high incidence of different diseases, and has significantly contributed to 
morbidity and mortality around the world. It represents a clustering of metabolic disorders and 
cardiovascular risk factors including: insulin resistance, hyperinsulinemia, central obesity, 
glucose intolerance or diabetes mellitus, atherogenic dyslipidemia, hypertension, endothelial 
dysfunction, prothrombotic and proinflammatory states [1, 2, 3]. In animal models high-fructose 
diets induce features of MetS including weight gain, insulin resistance, hypertriglyceridemia, 
and hypertension [4, 5, 6]. 
Based on different studies, it has been suggested that oxidative stress (OxS) is a common 
pathway through which various risk factors for several diseases exert their deleterious effects. 
OxS is a well-recognized mechanism playing important role in many pathological conditions 
[7], and several human diseases have been closely related to oxidative stress [8]. OxS is 
associated with pathogenesis of diabetes/pre-diabetes, obesity, cardiovascular diseases, 
neurodegenerative disorders, cancer, ageing, inflammation, apoptosis, etc. In diabetes OxS 
decreases insulin secretion from pancreatic β-cells and impairs glucose uptake in skeletal 
muscles and fat tissues [9]. Violation of intracellular glucose balance due to chronic 
hyperglycemia promotes intensification of free radical oxidation and inhibition of antioxidant 
defensive system in brain cells. This could serve as an independent factor that causes damage 
of neurons or their death. Thus, we can assume that formation of chronic OxS by diet or by 
genetic alterations may lead to cognitive decline. 
Pharmacological therapy is a critical step in management of patients with MetS when lifestyle 
modifications fail to achieve the therapeutic goals. In this study we examined whether 
Piracetam, phytoalexin Resveratrol and propylene glycol extract of Royal jelly could 
ameliorate fructose-induced cognitive impairment and OxS in rats with experimental MetS. 
Piracetam (PIR) is one of the most common neuroprotective drugs. In neurological practice it 
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is prescribed for atherosclerosis, vascular Parkinsonism, and 
other diseases with symptoms of chronic cerebrovascular 
insufficiency, which manifest themselves in impaired memory, 
learning, brain metabolism, and mental capacity [10, 11]. 
Royal jelly (RJ) is a natural bee product that has beneficial 
properties for human body (antimicrobial, anti-inflammatory, 
antiviral, antispasmodic, regenerative, bio stimulating, tonic, 
anti-aging). RJ is frequently used to treat cardiovascular 
diseases: ischemia, hypotension, anemia and hypertension. It 
has positive effects in treatment of atherosclerosis and 
coronary heart disease [12, 13, 14]. 
Resveratrol (RVT) is a phytoalexin contained in grapes, 
Japanese knotweed Polygonum, cowberry, peanut, and it exists 
mainly as a trans-form in nature. RVT is a powerful 
antioxidant that improves insulin sensitivity, prevents decline 
in cognitive functions, inhibits oxidative stress, etc [15, 16]. 
Indeed, RVT consumption has been shown to exert beneficial 
metabolic effects, regulate glucose homeostasis, and protect 
against chronic metabolic diseases, including diabetes [17, 18]. 
Therefore, a pre-clinical study was conducted to determine the 
effects of orally administered PIR, RJ and RVT on cognitive 
functions and oxidative stress markers in an animal model of 
diet-induced MetS. 
 
Materials and methods  
Experimental Animals 
A total of 50 healthy male albino rats (6 weeks old) weighing 
180-220 g were used in this study. They were housed in 
regular cages situated in an animal room at constant 
temperature (22±2 ºC) with 12 h light/dark cycle and had free 
access to standard pellet diet and water (ad libitum). 
All animal studies were conducted according to European 
Convention for the Protection of Vertebrate Animals Used for 
Experimental and Other Scientific Purpose (Strasbourg, 1986), 
Directive 2010/63/EU on the protection of animals used for 
scientific purposes, and were approved by the Institutional 
Animal Care Committee. 
 
Chemicals and Reagents 
Fructose was obtained from Galam Ltd. (Israel), 5% solution 
of Piracetam was obtained from Galychfarm (Ukraine), 
Resveratrol (Evelor) was purchased from Supplements Ltd, 
Cyprus, and propylene glycol extract of Royal jelly was 




The animals were randomly assigned into 5 experimental 
groups of ten each, as given below: 
1) Group-I: intact rats (passive control), fed with standard 
pellet diet and having free access to water. 
2) Group-F: rats with MetS induced by 60% fructose 
solution (instead of water) during 8 weeks (active 
control). 
3) Group-F+PIR: animals with experimental MetS that were 
treated with Piracetam (500 mg/kg/day). 
4) Group-F+RJ: rats with experimental MetS that were 
treated with propylene glycol extract of Royal jelly (1, 5 
mg/kg/day). 
5) Group-F+RVT: animals with experimental MetS that 
were treated with Resveratrol (20 mg/kg/day). 
All studied drugs (PIR, RJ, RVT) were administered orally for 
14 days during last 2 weeks of MetS induction. 
 
Behavioral Testing 
Behavioral testing was conducted under the room illumination 
(60W light) between 12:00–17:00 daily following a 1 hr 
period during which the rats were habituated to the testing 
room. 
Passive avoidance test (PAT) is a widely accepted simple and 
rapid means of memory testing. Passive avoidance response 
was determined using an apparatus, which consisted of an 
illuminated and dark compartments adjoining each other 
through a guillotine door. The test was conducted for 2 
consecutive days at the same time each day. On the first day 
(learning trial) each rat was placed in the illuminated 
compartment facing away from the dark compartment. Briefly, 
during the training sessions 180 sec adaptation and aversion 
trials in the apparatus were achieved. Once the rat enters 
completely into the dark compartment, it receives 5 strokes 
with electric shock (1 mA, 1 sec) were delivered at 5-second 
intervals through the stainless steel grid floor. The amount of 
time it took for the rat to enter into the dark compartment was 
recorded automatically, and described as step-through latency 
or latent period (LP). 
After 24 hr, following the training sessions, the avoidance of 
the dark shock-associated compartment and the latency to 
enter the dark compartment were recorded to present as 
memory retention trial within 180 sec. Nonetheless, a latency 
of 180 sec was given to those animals that did not enter the 
dark compartment within the experimentation period. Fraction 
of time spent in dark and bright compartment for each rat was 
noted [19, 20]. 
 
Oxidative Stress Markers 
Venous blood (5 ml) was collected from each animal after 
over-night fasting (>10 hr). Serum was then obtained, frozen 
and stored at −20 °C for further analysis. Analysis was 
performed immediately after defrosting of the samples. 
State of the antioxidant defensive system in given 
experimental conditions was estimated by determining the 
activity of superoxide dismutase (SOD) [21]. The principle of 
the total superoxide dismutase (EC 1.1.15.1.1) enzyme activity 
method is based on the inhibition of nitroblue tetrazolium 
(NBT) reduction by O2– generated by the xanthine/xanthine 
oxidase system. One unit of SOD was defined as the enzyme 
amount causing 50% inhibition in the NBT reduction rate [21]. 
Total SOD activity was expressed as units per milligram 
protein (U/mg protein). 
The intensity of lipid peroxidation was measured by estimating 
serum malondialdehyde (MDA) levels. This method depends 
on the formation of MDA as an end product of lipid 
peroxidation which reacts with thiobarbituric acid (TBA) 
producing thiobarbituric acid reactive substance (TBARS), a 
pink chromogen, which can be measured 
spectrophotometrically at 532 nm. An MDA standard was 
used to construct a standard curve against which readings of 
the samples were plotted [22]. 
Oxidative modification of proteins in serum was assessed by 
early (aldehydephenylhydrazones, APH, λ=270 nm) and late 
(ketophenylhydrazones, KPH, λ=363 nm) markers of oxidative 
degradation of proteins using standard spectrophotometric 
method [22]. APH and KPH levels were expressed as standard 
units per milligram protein. 
 
Statistical Analysis 
The results were analyzed with Stat Plus 2006 software 
(Analyst Soft; www.analystsoft.com). Data were expressed as 
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means ± S.E.M. (n = 10). The statistical significance of 
differences (p) was evaluated by nonparametric Mann–
Whitney U-test. The differences between the samples were 
significant at p<0.05. 
 
Results 
Effects on Behavioral Testing 
During the passive avoidance test there was no significant 
difference between all treatment groups in the initial latent 
period (LP) to enter the dark compartment, time spent in dark 
and bright compartments. Therefore any differences seen 
subsequently are a reflection of differences in the retrieval and 
are not related to the initial baseline activities. 
However, there were some differences in this parameter 
between Group-I and Group-F while testing the animals 24 
hours after initial testing (Fig. 1). LP in Group-I significantly 
exceeded initial values (p<0.05), and it was an evidence of 
effective learning of rats in this group. However, LP in Group-
F was less by 42.8% (p<0.05) as compared to Group-I. 
 
 
# – statistically significant difference from Group-I (p < 0.05); * – 
statistically significant difference from Group-F (p < 0.05) 
 
Fig 1: Effect of PIR, RVT and RJ on step-through passive avoidance 
test 
 
It should be noted that during passive avoidance test, rats 
treated by RVT, RJ and PIR took longer time to enter the dark 
compartment as compared to rats with MetS. Oral 
administration of all studied drugs in rats with MetS results in 
significant increase of step-through latency of passive-
defensive reflex on the second day of the test (Fig. 1). RJ, 
RVT and PIR increased the duration of LP in the range 76.7–
107.6% (p<0.05) as compared to a group of animals with MetS 
(Fig. 1). Longer latency indicates good retrieval of learned 
behavior. 
 
Oxidative Stress Markers 
It was established that deterioration of memory as an evidence 
of cognitive deficit in animals with MetS was accompanied by 
a significant activation of lipid peroxidation and oxidative 
modification of proteins in rat serum (Fig. 2, 3). 
Hyper activation of lipid peroxidation and development of 
oxidative stress was confirmed by the growth of serum MDA 
level in Group-F by 50.9% (p<0.05) as compared to Group-I 
(Fig. 2). The levels of APH and KPH were also increased by 
15.8% (p<0.05) and 15.5% (p<0.05) in comparison with group 
of intact animals (Fig. 4, 5). Along with activation of lipid 
peroxidation and oxidative modification of proteins in rats 
with MetS there was a decrease by 31.6% (p<0.05) in activity 
of a key antioxidant enzyme (SOD) (Fig. 3). 
 
# – statistically significant difference from Group-I (p < 0.05); * – 
statistically significant difference from Group-F (p < 0.05) 
 




# – statistically significant difference from Group-I (p < 0.05); * – 
statistically significant difference from Group-F (p < 0.05) 
 




# – statistically significant difference from Group-I (p < 0.05); * – 
statistically significant difference from Group-F (p < 0.05) 
 




# – statistically significant difference from Group-I (p < 0.05) 
 
Fig 5: Effect of PIR, RVT and RJ on KPH level in serum of fructose-
drinking rats. 
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Oral administration of the studied drugs during 14 days 
resulted in suppression of activity of free radical oxidation of 
lipids and proteins. Significant reduction in serum MDA levels 
was noted in all experimental groups (Fig. 2). Moreover, the 
most expressive diminution of this marker by 32.4% (p<0.05) 
was observed in the group of animals receiving Resveratrol. 
Less decrease of MDA level by 24.3% (p<0.05) and 23.0% 
(p<0.05) were noted in Group-F+RJ and Group-F+PIR as 
compared to Group-F (Fig. 2). It has been also ascertained that 
after administration of propylene glycol extract of Royal jelly, 
Piracetam and Resveratrol the content of a late marker of 
oxidative proteins degradation (KPH) in rat serum was 
reduced by diminished by 9.2%, 6.5% and 5.4% respectively, 
but these changes were not significant (Fig. 5). Regarding the 
early marker of oxidative proteins degradation (APH) in rat 
serum, only RJ extract was shown to decrease it by 14.6% 
(p<0.05). However, other drugs did not significantly influence 
APH content in serum of rats with metabolic syndrome (Fig. 
4). 
It has been also established that PIR, RVT and RJ increase 
activity of a key antioxidant enzyme (SOD) in rat serum by 
7.6% (p>0.05), 25.1% (p>0.05) and 66.3% (p<0.05) 
respectively as compared to Group-F (Fig. 3). 
 
Discussion 
Thus, experimental modeling of MetS in rats leads to 
impairment of training and retrieval of learned behavior. Our 
results indicate that administration of Piracetam, propylene 
glycol extract of Royal jelly and phytoalexin Resveratrol is 
capable to prevent accelerated development of cognitive 
deficits in rats with MetS. 
Inhibition of cognitive functions in animals with experimental 
MetS was accompanied by development of oxidative stress, 
which manifested in the form of excessive lipids/proteins 
peroxidation and inhibition of antioxidant protection. In turn, 
the lack of a considerable increase of APH along with 
significant rise of KPH in rats with MetS may indicate an 
absence of acute destructive changes in this condition and be 
the evidence of its chronic course. All studied drugs can 
suppress reactions of free radical oxidation of lipids and 
proteins that are activated in rats with experimental MetS and 
may influence its course and development of complications. 
This study indicates an important role of oxidative stress in 
development of cognitive disorders that appear in consequence 
of metabolic syndrome. At the same time, inhibition of free 
radical oxidation reactions in experimental MetS by studied 
drugs may play a key role in their cerebroprotective properties. 
 
Conclusion 
Experimental MetS induced by 60% fructose solution in rats 
leads to impairment of cognitive functions (deterioration of 
learning process), based on development of oxidative stress. 
Propylene glycol extract of Royal jelly and Resveratrol show 
pronounced antiamnesic activity in rats with MetS. All studied 
drugs inhibit reactions of free radical oxidation in varying 
degree. According to obtained data, the largest antiamnesic 
and antiradical efficacy is typical for propylene glycol extract 
of Royal jelly. 
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